LINE

Text:AAAPrint
Society

U.S. approves more tests for TCM

1
2015-06-29 08:04Global Times Editor: Li Yan

The U.S. Food and Drug Administration recently approved further clinical trials for a type of traditional Chinese medicine for pancreatic cancer treatment, media reported Sunday.

Kanglaite, the anticancer drug, contains ingredients extracted from coix seed, which is an important ingredient in some traditional Chinese medicine.

Li Dapeng, research team leader, said the clinical trial will involve 750 people and cost about $50 million. It will be carried out in China, the U.S. and Europe in the coming three to four years, reported the Xinhua News Agency.

If the drug successfully passes phase III of clinical trials, it is likely to become the first injectible medication involving traditional Chinese medicine to enter the U.S. market.

Related news

MorePhoto

Most popular in 24h

MoreTop news

MoreVideo

News
Politics
Business
Society
Culture
Military
Sci-tech
Entertainment
Sports
Odd
Features
Biz
Economy
Travel
Travel News
Travel Types
Events
Food
Hotel
Bar & Club
Architecture
Gallery
Photo
CNS Photo
Video
Video
Learning Chinese
Learn About China
Social Chinese
Business Chinese
Buzz Words
Bilingual
Resources
ECNS Wire
Special Coverage
Infographics
Voices
LINE
Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2018 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.